市场调查报告书
商品编码
1298852
非PVC输液袋市场:2023-2028年全球行业趋势、份额、规模、增长、机会和预测Non-PVC IV Bags Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球非PVC输液袋市场规模达到17亿美元。展望未来,IMARC集团预计,到2028年,市场规模将达到26亿美元,在2023-2028年期间呈现7.5%的增长率(CAGR)。
非聚氯乙烯(non-PVC)静脉注射(IV)袋是用聚丙烯、聚乙烯、共聚酯-醚和乙烯-醋酸乙烯薄膜制造的。它们专门用于包装补液和储存某些抗生素和镇痛剂,供医院和兽医使用。此外,它们可以广泛用于冷库,而不会抑制储存物品的质量和保质期。与经常面临药物和容器相互作用问题的PVC静脉输液袋不同,这些袋子提供了更好的安全性,降低了污染的风险,提高了使用的便利性。因此,非PVC静脉输液袋在肠外营养、肿瘤学、化疗和靶向药物输送方面有广泛的应用。
该市场主要由大众中不断上升的医院获得性感染(HAI)的发生率所驱动。再加上需要静脉注射抗生素的病人不断涌入医疗机构,这为非PVC静脉输液袋的使用提供了动力。另外,由于单室非PVC静脉输液袋便于管理、运输和处置,在静脉滴注和其他混合物中的广泛采用,也大大促进了产品销售。除此之外,全球越来越多的护理点(POC)设施和对家庭护理设置的偏爱,特别是对老年人群,都对市场增长产生了有利的影响。由乙烯-醋酸乙烯(EVA)制成的静脉输液袋的不断普及进一步推动了市场的发展。由于这些袋子对无孔基质有很好的粘附性,而且价格合理,所以它们在全球范围内被医疗专业人士广泛使用。其他一些为市场创造积极前景的因素包括对生物惰性医疗用品的需求增加,医疗基础设施的大量发展和广泛的研究与开发(R&D)活动。
The global non-PVC IV bags market size reached US$ 1.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2028, exhibiting a growth rate (CAGR) of 7.5% during 2023-2028.
Non-polyvinyl chloride (non-PVC) intravenous (IV) bags are manufactured using polypropylene, polyethylene, copolyester-ether, and ethylene-vinyl acetate films. They are specifically designed for packaging rehydration solutions and storing certain antibiotics and analgesics for hospital and veterinary usage. Moreover, they can be extensively utilized in cold storage without inhibiting the quality and shelf-life of the stored items. Unlike PVC IV bags that often face drug and container interaction problems, these bags provide improved safety, lowered risks of contamination and enhanced convenience of usage. As a result, non-PVC IV bags find extensive applications in parenteral nutrition, oncology, chemotherapy, and targeted drug deliveries.
The market is primarily driven by the rising incidences of hospital-acquired infections (HAIs) among the masses. Coupled with the increasing influx of patients requiring intravenous antibiotics across healthcare facilities, this has provided a boost to the uptake of non-PVC IV bags. Also, the widespread adoption of single-chambered non-PVC IV bags in IV drips and other mixtures due to their convenience of management, transportation, and disposal is significantly contributing to the product sales. In addition to this, the growing number of point-of-care (POC) facilities across the globe and the preference for home care setups, especially for the geriatric population, are favorably impacting the market growth. The market is further driven by the escalating popularity of IV bags made up of ethylene-vinyl acetate (EVA). Since these bags offer excellent adhesion to non-porous substrates at an affordable price point, they are widely utilized by healthcare professionals on the global level. Some of the other factors creating a positive outlook for the market include the augmenting demand for biologically inert medical supplies, considerable developments in the healthcare infrastructure and extensive research and development (R&D) activities.
IMARC Group provides an analysis of the key trends in each sub-segment of the global non-PVC IV bags market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on material, product, content, application and end user.
Ethylene Vinyl Acetate
Copolyester-ether
Polypropylene
Others
Multi Chamber
Single Chamber
Frozen Mixture
Liquid Mixture
Chemotherapy
Targeted Drug Delivery
Glucose Injection
Sodium Chloride Solution
Electrolyte Injection
Nutrient Injection
Others
Hospitals
Clinics
Emergency Service Centers
Ambulatory Surgical Centers
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Fresenius SE & Co. KGaA, JW Life Science Co. Ltd., Kraton Corporation (DL Chemical Co. Ltd.), Medline Industries LP, Persico S.p.a., Sealed Air Corporation and Sippex IV bags.
Key Questions Answered in This Report
1. What was the size of the global non-PVC IV bags market in 2022?
2. What is the expected growth rate of the global non-PVC IV bags market during 2023-2028?
3. What are the key factors driving the global non-PVC IV bags market?
4. What has been the impact of COVID-19 on the global non-PVC IV bags market?
5. What is the breakup of the global non-PVC IV bags market based on the material?
6. What is the breakup of the global non-PVC IV bags market based on the product?
7. What is the breakup of the global non-PVC IV bags market based on content?
8. What is the breakup of the global non-PVC IV bags market based on the end user?
9. What are the key regions in the global non-PVC IV bags market?
10. Who are the key players/companies in the global non-PVC IV bags market?